Cumberland Pharmaceuticals
Price & Volume
Stats
See more52W Range | $1.46-$7.20 |
Market Cap | $100.8M |
Shares Short | 372,727 |
Financials
See moreRevenue (12 Mos) | $41.9M |
Revenue Growth (YoY) | -22% |
Gross Profit (12 Mos) | $34.7M |
Diluted EPS | -$0.49 |
News
See moreYahoo Finance • 3 months ago
Cumberland outlines $100M Apotex deal while shifting to development-focused strategy
Yahoo Finance • 3 months ago
Cumberland Pharmaceuticals (CPIX) Integrates Commercial Business with Apotex
Yahoo Finance • 5 months ago
Cumberland (CPIX) Q4 2025 Earnings Call Transcript
Yahoo Finance • 5 months ago
Cumberland Pharmaceuticals Non-GAAP EPS of $0.11, revenue of $44.5M
About
CEO | Mr. A. J. Kazimi MBA |
CFO | Mr. John Michael Hamm C.M.A. |
Address | 1600 West End Avenue, Nashville, TN, United States, 37203 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 93 |